A Trial of MitoQ for the Treatment of People With Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

November 30, 2007

Conditions
Parkinson's Disease
Interventions
DRUG

MitoQ

Two doses will be compared to placebo: 40 or 80 mg of MitoQ once daily for a period of 12 months.

Trial Locations (13)

Unknown

Westmead Hospital, Sydney

The Royal Brisbane and Women's Hospital, Brisbane

Austin Hospital, Melbourne

Dunedin Hospital, Dunedin

Auckland City Hospital, Auckland

Van der Veer Institute for Parkinson's and Brain Research, Christchurch

Waikato Hospital, Hamilton

Hawke's Bay Hospital, Hastings

Nelson Hospital, Nelson

Palmerston North Hospital, Palmerston North

Tauranga Hospital, Tauranga

Wellington Hospital, Wellington

Whangarei Hospital, Whangarei

All Listed Sponsors
lead

Antipodean Pharmaceuticals, Inc.

INDUSTRY

NCT00329056 - A Trial of MitoQ for the Treatment of People With Parkinson's Disease | Biotech Hunter | Biotech Hunter